Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Selectively binds oxytocin receptors in uterine smooth muscle, stimulates rhythmic contractions, increases the frequency of existing contractions and raises uterine tone. The effect is longer lasting than oxytocin.
Indications / reported uses
Prevention of postpartum haemorrhage due to uterine atony following caesarean section or vaginal delivery; a single dose is administered only after delivery under specialist obstetric supervision. It must not be used to induce labour.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Carbetocin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Carbetocin Permitted Daily Exposure (PDE) report (the Carbetocin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Carbetocin Occupational Exposure Limit (OEL) report (the Carbetocin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.